D-0656-2026 Class II Ongoing

Recalled by ACCORD HEALTHCARE, INC. — Raleigh, NC

FDA drug recall D-0656-2026 was initiated by ACCORD HEALTHCARE, INC. on Jun 8, 2026 and is designated Class II. Reason for recall: Subpotent Drug The recall status is ongoing. Affected quantity: 6432 bottles.

Recall details

Product Type
Drugs
Report Date
Jul 8, 2026
Initiation Date
Jun 8, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
6432 bottles

Product description

Levothyroxine Sodium Tablets, USP, 300 mcg (0.3mg), 90 Tablets bottles, Rx only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: lntas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, INDIA, NDC 16729-458-15.

Reason for recall

Subpotent Drug

Distribution pattern

US Nationwide.

Code information

Lot # D2401522, Exp Date: 06/2026.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0656-2026
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0656-2026. Report a data issue: hello@regdatalab.com.